
Bahar Alawi Craigo
Examiner (ID: 5706)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1759, 1699, 4131, 1623, 1673 |
| Total Applications | 926 |
| Issued Applications | 371 |
| Pending Applications | 113 |
| Abandoned Applications | 462 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19613165
[patent_doc_number] => 20240398845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF CARDIAC DISEASES IN NON-HUMAN MAMMALS EXCLUDING FELINES, IN PARTICULAR CANINES
[patent_app_type] => utility
[patent_app_number] => 18/578118
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13561
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18578118
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/578118 | USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF CARDIAC DISEASES IN NON-HUMAN MAMMALS EXCLUDING FELINES, IN PARTICULAR CANINES | Jul 25, 2022 | Pending |
Array
(
[id] => 19388018
[patent_doc_number] => 20240277888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => BIODEGRADABLE AND REUSABLE CELLULOSIC MICROPOROUS SUPERABSORBENT MATERIALS
[patent_app_type] => utility
[patent_app_number] => 18/580652
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18580652
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/580652 | BIODEGRADABLE AND REUSABLE CELLULOSIC MICROPOROUS SUPERABSORBENT MATERIALS | Jul 19, 2022 | Pending |
Array
(
[id] => 19884146
[patent_doc_number] => 12269838
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Composition of mannuronic diacid
[patent_app_type] => utility
[patent_app_number] => 17/860468
[patent_app_country] => US
[patent_app_date] => 2022-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8015
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17860468
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/860468 | Composition of mannuronic diacid | Jul 7, 2022 | Issued |
Array
(
[id] => 18143347
[patent_doc_number] => 20230017195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/856239
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11973
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17856239
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/856239 | COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS | Jun 30, 2022 | Abandoned |
Array
(
[id] => 18034762
[patent_doc_number] => 20220378977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => DERMAL FILLER
[patent_app_type] => utility
[patent_app_number] => 17/843155
[patent_app_country] => US
[patent_app_date] => 2022-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5930
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17843155
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/843155 | DERMAL FILLER | Jun 16, 2022 | Pending |
Array
(
[id] => 18056376
[patent_doc_number] => 20220387462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => Use Of Migalastat For Treating Fabry Disease In Pregnant Patients
[patent_app_type] => utility
[patent_app_number] => 17/838820
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10577
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838820
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/838820 | Use Of Migalastat For Treating Fabry Disease In Pregnant Patients | Jun 12, 2022 | Pending |
Array
(
[id] => 17881072
[patent_doc_number] => 20220296549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => Small Molecule Agents, Compositions, and Formulations, for Internal Use, Displaying Inhibitory Activity Against Gram-positive and/or Gram-negative Organisms
[patent_app_type] => utility
[patent_app_number] => 17/832786
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19922
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17832786
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/832786 | Small Molecule Agents, Compositions, and Formulations, for Internal Use, Displaying Inhibitory Activity Against Gram-positive and/or Gram-negative Organisms | Jun 5, 2022 | Pending |
Array
(
[id] => 19402153
[patent_doc_number] => 20240285664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => LINE-1 INHIBITORS AS COGNITIVE ENHANCERS
[patent_app_type] => utility
[patent_app_number] => 18/566413
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18566413
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/566413 | LINE-1 INHIBITORS AS COGNITIVE ENHANCERS | Jun 2, 2022 | Pending |
Array
(
[id] => 20633417
[patent_doc_number] => 12594280
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-07
[patent_title] => Antiviral compositions for treating the flu
[patent_app_type] => utility
[patent_app_number] => 17/828245
[patent_app_country] => US
[patent_app_date] => 2022-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 27
[patent_no_of_words] => 3767
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17828245
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/828245 | Antiviral compositions for treating the flu | May 30, 2022 | Issued |
Array
(
[id] => 19263596
[patent_doc_number] => 20240207293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => COMPOSITION FOR IMPROVING INTESTINAL MICROBIAL POPULATION COMPRISING GALACTOSE
[patent_app_type] => utility
[patent_app_number] => 18/563015
[patent_app_country] => US
[patent_app_date] => 2022-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4811
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563015
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/563015 | COMPOSITION FOR IMPROVING INTESTINAL MICROBIAL POPULATION COMPRISING GALACTOSE | May 30, 2022 | Pending |
Array
(
[id] => 17805787
[patent_doc_number] => 20220257622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => COMPOSITION FOR MAINTAINING LACTOBACILLUS DOMINANCE
[patent_app_type] => utility
[patent_app_number] => 17/738286
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5606
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17738286
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/738286 | COMPOSITION FOR MAINTAINING LACTOBACILLUS DOMINANCE | May 5, 2022 | Pending |
Array
(
[id] => 19279776
[patent_doc_number] => 20240216248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => MICROBIAL GLYCOLIPIDS
[patent_app_type] => utility
[patent_app_number] => 18/288903
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31114
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18288903
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/288903 | MICROBIAL GLYCOLIPIDS | Apr 24, 2022 | Pending |
Array
(
[id] => 17759950
[patent_doc_number] => 20220233562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => COMPOSITION COMPRISING HMOs FOR PREVENTING OR REDUCING NOCICEPTION
[patent_app_type] => utility
[patent_app_number] => 17/723135
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17723135
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/723135 | COMPOSITION COMPRISING HMOs FOR PREVENTING OR REDUCING NOCICEPTION | Apr 17, 2022 | Abandoned |
Array
(
[id] => 17759967
[patent_doc_number] => 20220233579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => HYDROGEN SULFIDE RELEASING POLYMER COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/717396
[patent_app_country] => US
[patent_app_date] => 2022-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11420
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17717396
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/717396 | HYDROGEN SULFIDE RELEASING POLYMER COMPOUNDS | Apr 10, 2022 | Abandoned |
Array
(
[id] => 17748155
[patent_doc_number] => 20220226358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => MIXTURE OF INOSITOL DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/714240
[patent_app_country] => US
[patent_app_date] => 2022-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714240
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/714240 | MIXTURE OF INOSITOL DERIVATIVES | Apr 5, 2022 | Abandoned |
Array
(
[id] => 19248834
[patent_doc_number] => 20240199821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => WATER-ABSORBING RESIN
[patent_app_type] => utility
[patent_app_number] => 18/553129
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18553129
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/553129 | WATER-ABSORBING RESIN | Mar 30, 2022 | Pending |
Array
(
[id] => 19555355
[patent_doc_number] => 20240367147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => METHOD FOR PRODUCING WATER-SOLUBLE POLYMER AND METHOD FOR PRODUCING WATER-ABSORBING RESIN
[patent_app_type] => utility
[patent_app_number] => 18/552847
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552847
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552847 | METHOD FOR PRODUCING WATER-SOLUBLE POLYMER AND METHOD FOR PRODUCING WATER-ABSORBING RESIN | Mar 30, 2022 | Pending |
Array
(
[id] => 19049278
[patent_doc_number] => 20240091247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => INHIBITOR FOR CHRONIC MYELOID LEUKEMIA STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 18/271829
[patent_app_country] => US
[patent_app_date] => 2022-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8969
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18271829
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/271829 | INHIBITOR FOR CHRONIC MYELOID LEUKEMIA STEM CELLS | Feb 20, 2022 | Pending |
Array
(
[id] => 19112867
[patent_doc_number] => 20240124617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => COMPOSITIONS COMPRISING EXOPOLYSACCHARIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/546073
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18546073
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/546073 | COMPOSITIONS COMPRISING EXOPOLYSACCHARIDES AND USES THEREOF | Feb 9, 2022 | Pending |
Array
(
[id] => 19691198
[patent_doc_number] => 20250009743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => METHODS OF TREATING CANCERS USING STING AGONISTS
[patent_app_type] => utility
[patent_app_number] => 18/274823
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41269
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -62
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274823
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/274823 | METHODS OF TREATING CANCERS USING STING AGONISTS | Feb 9, 2022 | Pending |